Emmaus Life Sciences Issues Statement in Response to Announcement by AFH Holding & AdvisoryJanuary 25, 2013 Read More
Emmaus Medical Announces Completion of Enrollment for its Phase 3 Sickle Cell Disease TrialDecember 03, 2012 Read More
Emmaus CEO Yutaka Niihara, M.D., Issues Statement In Connection with Status of Company’s Phase III FDA Sickle Cell Treatment TrialsNovember 22, 2012 Read More
